(lp0
S'Ampio Pharmaceuticals - Running On Fumes Seeking Alpha - Feb 1, 2017 My interest in Ampio Pharmaceuticals Inc.,  was established several days ago during the Optometric Leaders Forum in Montreal, Canada.Ampio Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 01 - Equities.com'
p1
aS'Ampio Pharmaceuticals Provides Corporate Update PR Newswire  - Mar 20, 2017 ENGLEWOOD, Colo., March 20, 2017 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. , a leader in the development of Ampion, a low molecular weight fraction of human serum albumin with anti-inflammatory properties, announced an&nbsp;...Ampio Pharmaceuticals, Inc.  in-depth technical analysis - Post AnalystAs Ampio Pharmaceuticals, Inc. Trades Do Analysts Recommend You Sell? - The De Soto Edge'
p2
aS'0.59 MarketWatch - Apr 18, 2011 Ampio Pharmaceuticals Inc. Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions.'
p3
aS'News Ampio Pharmaceuticals Inc.AMPE Wall Street Journal - May 20, 2011 News Ampio Pharmaceuticals Inc.AMPE. Significant News Only. 03/28/17; Press Release. Ampio Pharmaceuticals Amends Warrant Agreement.'
p4
aS'Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering PR Newswire  - Aug 29, 2016 ENGLEWOOD, Colo., Aug. 29, 2016 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.  today announced that it has entered into a securities purchase agreement with an institutional investor providing for the registered sale of 5,000,000&nbsp;...'
p5
aS'Ampio Pharmaceuticals, Inc. Announces Updates On the Regulatory Path for FDA ... PR Newswire  - Oct 14, 2015 ENGLEWOOD, Colo., Oct. 14, 2015 /PRNewswire/ - Ampio Pharmaceuticals, Inc.  today announced that Ampio met with the Division of the Transplant and Ophthalmology Products of the FDA to discuss the results of the OptimEyes&nbsp;...'
p6
aS"Update - Ampio Pharmaceuticals Provides Corporate Update PR Newswire  - Mar 22, 2017 ENGLEWOOD, Colo., March 22, 2017 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. , a leader in the development of Ampion, a low molecular weight fraction of human serum albumin with anti-inflammatory properties, today announced&nbsp;...Colorado biotech's accountants express 'substantial doubt' about firm's future - Denver Business Journal"
p7
aS'Ampio Pharmaceuticals, Inc.  Recent Ownership Changes Post Analyst - Apr 17, 2017 Ampio Pharmaceuticals, Inc.  reached 13.17% versus a 1-year low price of $0.52. The stock was last seen -1.46% lower, reaching at $0.59 on 14th April.Ampio Pharmaceuticals, Inc.  Reviewed By Analysts - The De Soto Edge'
p8
aS'Ampio Pharmaceuticals  Stock Tanks Today after Treatment Fails To Reach ... TheStreet.com - Apr 20, 2015 NEW YORK  -- Ampio Pharmaceuticals  shares are down 65.76% to $2.71 in trading on Monday after the biopharmaceutical company announced that the multiple injection STRIDE study for pain reliever Ampion did not reach its primary&nbsp;...AMPIO Announces Ampion STRIDE Study Results - PR Newswire '
p9
aS'Ampio Pharmaceuticals Inc.  Soars 8.75% on April 11 Equities.com - Apr 11, 2017 Ampio Pharmaceuticals Inc.  had a good day on the market for Tuesday April 11 as shares jumped 8.75% to close at $0.62.'
p10
a.